This is the banner text
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
The list honors investment firms that remain actively involved with the businesses in which they invest and that have earned the trust of the entrepreneurs they support.
Samit has played key roles in pharma services and supported the growth of several portfolio companies.
The first FDA-Cleared microneedling treatment and category leader in dermatology and aesthetics continues to build its legacy with best-in-class technology
Crown Laboratories to acquire Revance Therapeutics for $924M, creating a leading aesthetics and skincare company with innovative product lines and global reach.
Carlin Consumer Health has acquired joint and muscle care brand, Penetrex, from Wellbeam Consumer Health, under undisclosed terms.
Hildred Capital today announced the closing of a multi-asset continuation fund led by Lexington Partners, one of the world’s largest managers of secondary private equity and co-investment funds, and a leading group of limited partners.
Hildred Capital Management, a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies,
binx health partners with Cardinal Health to distribute the binx io®, a rapid, FDA-cleared test for chlamydia and gonorrhea, improving access to care nationwide.
Mr. Righeimer will hold dual role as he continues to serve as CEO of Hyland's Naturals
SportsMed's 39th location expands the physical therapy company's multi-disciplinary services to Monmouth County, NJ
With new private equity ownership, Hello Bello will continue to deliver “Premium for All”.
Binx Health partners with Fisher Healthcare to increase access to convenient, routine testing for Chlamydia and Gonorrhea.
Carlin Consumer Health Acquires Infirst USA Holdings, LLC.
DermCare Management proudly announces three new acquisitions, expanding its presence across the country to a total of 68 practice locations.
Hyland's Naturals is launching a lineup of premium, multi-benefit supplements specifically designed for women.
SportsMed Physical Therapy acquired the two clinics comprising Mountainside Wellness.
Fortune magazine has selected Hyland's Naturals for the 2023 Fortune Best Workplaces in Manufacturing & Production™ List.
Hyland's Naturals has been certified as a Great Place To Work for the second consecutive year, with 84% of employees stating it is a great place to work.
Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers.
MedicoRx Specialty Pharmacy, Vasco Infusion and VascoRx Specialty Pharmacy subsidiaries to now operate under AleraCare brand name.
More than 70% of capital from the New York PE firm's first institutional fund has been deployed and reserved, sources said.
DermCare Management announces the completion of 3 acquisitions in the fourth quarter of 2022.
Will Righeimer, CEO of Hyland's Naturals, Elevates Focus on Empowering Employees and Cultivating Positive Workplace Culture.
Mr. Chapman joins Carlin from Advanced Vision Research (“AVR”), the consumer health division of Akorn Operating Company LLC.
Hildred Capital Management, LLC today announced that Orle Mulamekic has been appointed Managing Director and Chief Financial Officer.
Hildred Capital Management, today announced that Kevin Regan has been promoted to Vice President.
Hyland's Naturals, a leading consumer health company, today unveiled its lineup of new premium gummies in the vitamins, minerals, and supplements (VMS) category.
Crown Laboratories has finalized an agreement with Eclipse, a medical technology company, to acquire its global, aesthetics-focused assets.
DermCare Management, a quickly-growing and innovative family of brands focused on both medical and cosmetic dermatologic services, announced new partnerships with Stone Oak Dermatology, Irradiance Medical Group, Altman Dermatology, and Icecreamwala Dermatology today.
Hildred Capital Management LLC announced that it has closed its first institutional fund, Hildred Equity Partners II (the “Fund”) with total commitments of $362.5 million, exceeding its target.
HealthCare.com, a leading data-driven insurtech platform, announced today the extension of its recent Series C equity round, which was led by Oaktree Capital Management, L.P. (“Oaktree”) as well as existing investors AXIS Capital, Second Alpha and Link Ventures.
Hildred Capital Management, LLC (“Hildred”) and Bourne Partners Strategic Capital (“Bourne”), together with The Emerson Group (“Emerson”), launch Carlin Consumer Health (“Carlin”) to establish a preeminent consumer health business and to acquire leading over-the-counter (“OTC”) brands.
Kareo, a leader in cloud-based clinical and financial software, and PatientPop, a leader in practice growth technology, today announced the closing of their merger and the unveiling of the combined company’s new name.
Crown Laboratories has entered into a definitive agreement under to acquire StriVectin.
Financing led by OrbiMed, and includes Arrowmark Partners, Hildred Capital Management, Alta Life Sciences and Parian Global.
Announces unaudited 2020 full-year revenue of at least $45 million, representing growth of at least 63%, each above prior forecast
Butterfly Network’s mission is to enable universal access to superior medical imaging, making high quality ultrasound affordable, easy-to-use, globally accessible and intelligently connected.
Hildred Capital Management and Gemini Investors have completed a majority recapitalization of DermCare Management and Skin & Beauty Center Management.
Crown Laboratories Invests in cutting-edge technological capabilities in the microbiome space.
Crown Laboratories adds a portfolio of significant legacy skin care brands to its portfolio.
Pursuant to the terms of the Transaction Agreement, the Business Combination will be structured as a merger between Columbia Care and a newly-formed Delaware subsidiary of CGGC.
Crown Laboratories, a Hildred Capital Partners portfolio company, establishes aesthetics division with innovative, non-invasive product line.
Hildred Capital Partners portfolio company, Crown Laboratories, adds leading, all-natural product line in sunless tanning to the company’s dermatology portfolio.
Hildred Capital Partners will assume major stake in leading dermatology and skincare product company.
Hildred Capital Partners will assume major stake in leading dermatology and skincare product company.
The Solomons sold their pharma business for $28 billion, made 10 investments through their family office, and are now considering raising third-party capital.
Hildred Capital Partners with Athyrium Capital and Signet Healthcare takes major stake in leading contract development and manufacturing business.
